BIT
RARX

BlackRock Institutional Trust’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

BlackRock Institutional Trust’s Portfolio RARX Stock Details RARX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$224K Buy
+14,770
New +$201K ﹤0.01% 3576

Other funds holding RARX

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

BlackRock Institutional Trust's RARX Position: Q4 2016 in Review

BlackRock Institutional Trust opened a new position in Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q4 2016: 14,770 shares worth $224K. The stake represents ﹤0.01% of the portfolio and ranks #3576 among its holdings.

59 funds tracked by Wall St. Rank hold RARX as of Q4 2016.

  • BlackRock Institutional Trust held 14,770 shares of Ra Pharmaceuticals, Inc. Common Stock worth $224K as of Q4 2016.
  • Ra Pharmaceuticals, Inc. Common Stock was a new BlackRock Institutional Trust position in Q4 2016.
  • Ra Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3576 holding.
  • 59 funds tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.